Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI vs FP/Sal vs FP in Persistent Asthma
NCT02301975Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2015
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
A Phase 3 trial of fluticasone, vilanterol in asthma, sponsored by GSK. Started Mar 2015; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02301975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301975.